Conferences

2018 Conferences

This 5th annual event, held November 14-15 in Iselin, New Jersey, will gather a global audience of biosimilars experts and industry thought leaders to discuss biosimilar manufacturing and commercialization considerations specific to the United States.

The biosimilars industry is reaching a stage at which key stakeholders understand and accept biosimilars, as reflected in more tolerant legislation and an increased uptake of biosimilars across the globe. Over the coming years, the next waves of biosimilars will enter the market. Will the biosimilar be a successful contender and spark a competitive environment, or will the originator dominate? Can the payer, prescriber, and patient be convinced to switch? The conference, held September 26-27 in London, United Kingdom, will feature the experience of key opinion leaders, and help stakeholders evaluate market access opportunities and commercialization strategies with industry experts.

The European League Against Rheumatism’s (EULAR) Annual European Congress of Rheumatology, held from June 13-16 in Amsterdam, Netherlands, is a renowned forum for interaction between physicians, scientists, patients, health professionals, and representatives of the pharmaceutical industry worldwide.
The American Society of Clinical Oncology (ASCO) will host its annual meeting June 1-5, 2018, in Chicago, Illinois. The meeting will bring together more than 32,000 oncology professionals to discuss new treatments and ongoing controversies, following the theme of “Delivery Discoveries: Expanding the Reach of Precision Medicine.”
The American Conference Institute will hold its 9th annual Summit on Biosimilars on June 25-27, 2018, in New York, New York, where experts will discuss the future of biosimilars and formulate solutions to the complex regulatory and patent challenges ahead. 
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) will hold its 23rd annual conference from May 19-23, 2018, in Baltimore, Maryland, with a focus on real-world evidence, digital health, and the new landscape for health decision making.
The Alliance for Patient Access Annual National Policy and Advocacy Summit on Biologics and Biosimilars explores policies impacting prescribing and patient access to biologic and biosimilar therapies.
2017 Conferences
American Society of Hematology 2017 Annual Meeting and Exposition, the world’s most comprehensive hematology event, offers premier educational and scientific meetings and workshops for hematology professionals worldwide.
SMi Biosimilars North America 2017 explores novel and innovative strategies to advance biosimilar development, ensure optimal market access and commercialization, and comply with evolving regulatory requirements. 
The American College of Rheumatology's Annual Meeting is the world's premier rheumatology meeting. With over 450 educational sessions, the meeting provides opportunities for professional development and access to the latest rheumatology research and clinical applications.
The 2-day conference, Leading on Biosimilars, features presentations from key industry leaders, government agency officials, and academic experts. The interactive conference provides the opportunity to learn the most up-to-date information regarding regulatory, reimbursement, legal, political, and policy environments surrounding access to biosimilar products. 
The ESMO 2017 Congress, in partnership with the European Association for Cancer Research (EACR), will bring cancer researchers and clinicians together to enable collaboration and the exchange of ideas, from the laboratory to the bedside and back. This exciting partnership creates a unique cancer congress in Europe with huge scientific reach and the true potential to improve the lives of cancer patients.
The American Diabetes Association (ADA) will present its 77th Scientific Sessions from June 9-13, 2017, in San Diego, California. More than 13,000 international attendees will convene to learn about the most significant advances in diabetes care and research during this year's meeting, Experience New Horizons in Diabetes.
The American Society of Clinical Oncology (ASCO) will host its annual meeting on June 2-7, 2017, in Chicago, Illinois, at McCormick Place. The meeting will highlight the newest advances in caring for patients and survivors through the lens of this year's theme, Making a Difference in Cancer Care With You. Check back for biosimilars coverage at ASCO.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its 22nd Annual International Meeting in Boston, Massachusetts, from May 20-24, 2017. This year's meeting, Evidence and Value in a Time of Social and Policy Change, brought payers, researchers, and other stakeholders together to learn about drug development and regulatory issues in today's rapidly-changing healthcare environment, with several sessions on biologics and biosimilars. 
The annual meeting of the The American Academy of Allergy, Asthma & Immunology (AAAAI), brings together allergists, immunologists, allied health, and other healthcare professionals, and covers a variety of topics, including allergic disease, asthma, immunotherapy, practice management, and new technologies. The Center for Biosimilars is covering this meeting, held March 3-6, 2017, in Atlanta, GA.

Click here to view Biosimilars CME Activities

Click here to view Biosimilars PTCE Activities


Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2018 Intellisphere, LLC. All Rights Reserved.